CRISPR For Hair Loss
Moogene Medi of Korea shares an update on their topical anti-DHT therapies utilizing microbubble delivery and ultrasound technology with limited systemic exposure. HUTERA Hair Loss Treatment In November 2020, Follicle Thought introduced Moogene Medi as the first company officially working on a CRISPR gene editing therapy for hair loss. Over a year and a half…
Read More
Moogene Medi of South Korea is the first company to formally introduce a CRISPR-based gene editing hair loss therapy to the world. Description Of CRISPR Therapy For AGA Moogene has developed a microbubble-nanoliposomal delivery system to get gene editing particles directly into the dermal papilla cells of the hair follicle. First, a sequence of sgRNA…
Read More